Kwaan H
Int J Mol Sci. 2022; 23(9).
PMID: 35563651
PMC: 9101224.
DOI: 10.3390/ijms23095262.
Leth J, Ploug M
Front Cell Dev Biol. 2021; 9:732015.
PMID: 34490277
PMC: 8417595.
DOI: 10.3389/fcell.2021.732015.
Alshabi A, Shaikh I, Vastrad C
Biomolecules. 2019; 9(7).
PMID: 31311202
PMC: 6681318.
DOI: 10.3390/biom9070282.
Duffy M, McGowan P, Harbeck N, Thomssen C, Schmitt M
Breast Cancer Res. 2015; 16(4):428.
PMID: 25677449
PMC: 4423643.
DOI: 10.1186/s13058-014-0428-4.
Botkjaer K, Deryugina E, Dupont D, Gardsvoll H, Bekes E, Thuesen C
Mol Cancer Res. 2012; 10(12):1532-43.
PMID: 23038812
PMC: 3528818.
DOI: 10.1158/1541-7786.MCR-12-0349.
Expression of urokinase-type plasminogen activator (uPA), its receptor (uPAR), and inhibitor (PAI-1) in human breast carcinomas and their clinical relevance.
Andres S, Edwards A, Wittliff J
J Clin Lab Anal. 2012; 26(2):93-103.
PMID: 22467324
PMC: 6807482.
DOI: 10.1002/jcla.21488.
GATA factors in gastrointestinal malignancy.
Ayanbule F, Belaguli N, Berger D
World J Surg. 2011; 35(8):1757-65.
PMID: 21210118
DOI: 10.1007/s00268-010-0950-1.
Perspectives on Breast Cancer Management: Tailoring Treatment to the Individual Patient.
Thomssen C
Breast Care (Basel). 2010; 3(s1):21-23.
PMID: 20824005
PMC: 2930993.
DOI: 10.1159/000119749.
Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness.
Obermajer N, Doljak B, Kos J
Mol Cancer. 2009; 8:88.
PMID: 19845941
PMC: 2774675.
DOI: 10.1186/1476-4598-8-88.
Influence of preoperative core biopsies on uPA/PAI-1 expression in breast cancer tissue.
Haas S, Park T, Hahne J, Fischer H
Virchows Arch. 2008; 452(3):277-83.
PMID: 18196271
DOI: 10.1007/s00428-007-0563-8.
Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.
Ortiz-Zapater E, Peiro S, Roda O, Corominas J, Aguilar S, Ampurdanes C
Am J Pathol. 2007; 170(5):1573-84.
PMID: 17456763
PMC: 1854952.
DOI: 10.2353/ajpath.2007.060850.
Correlative studies on uPA mRNA and uPAR mRNA expression with vascular endothelial growth factor, microvessel density, progression and survival time of patients with gastric cancer.
Zhang L, Zhao Z, Ru G, Ma J
World J Gastroenterol. 2006; 12(25):3970-6.
PMID: 16810742
PMC: 4087704.
DOI: 10.3748/wjg.v12.i25.3970.
Clinicopathological significance of maspin expression in breast cancer.
Lee M, Suh C, Li Z
J Korean Med Sci. 2006; 21(2):309-14.
PMID: 16614520
PMC: 2734010.
DOI: 10.3346/jkms.2006.21.2.309.
A prognostic index for operable, node-negative breast cancer.
McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R
Br J Cancer. 2004; 90(10):1933-41.
PMID: 15138474
PMC: 2409476.
DOI: 10.1038/sj.bjc.6601826.
The myofibroblast is the predominant plasminogen activator inhibitor-1-expressing cell type in human breast carcinomas.
Offersen B, Nielsen B, Hoyer-Hansen G, Rank F, Hamilton-Dutoit S, Overgaard J
Am J Pathol. 2003; 163(5):1887-99.
PMID: 14578188
PMC: 1892443.
DOI: 10.1016/S0002-9440(10)63547-X.
Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer.
Kaneko T, Konno H, Baba M, Tanaka T, Nakamura S
Cancer Sci. 2003; 94(1):43-9.
PMID: 12708473
PMC: 11160168.
DOI: 10.1111/j.1349-7006.2003.tb01350.x.
Cyclooxygenase-2 expression correlates with uPAR levels and is responsible for poor prognosis of colorectal cancer.
Konno H, Baba M, Shoji T, Ohta M, Suzuki S, Nakamura S
Clin Exp Metastasis. 2002; 19(6):527-34.
PMID: 12405290
DOI: 10.1023/a:1020392309715.
Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
van der Pluijm G, Sijmons B, Vloedgraven H, van der Bent C, Drijfhout J, Verheijen J
Am J Pathol. 2001; 159(3):971-82.
PMID: 11549590
PMC: 1850470.
DOI: 10.1016/S0002-9440(10)61773-7.
Urokinase receptor and vascular endothelial growth factor are synergistically associated with the liver metastasis of colorectal cancer.
Konno H, Abe J, Kaneko T, Baba M, Shoji A, Sunayama K
Jpn J Cancer Res. 2001; 92(5):516-23.
PMID: 11376560
PMC: 5926736.
DOI: 10.1111/j.1349-7006.2001.tb01124.x.
Ca²+;-Dependent Neutral Protease (Calpain) Activity in Breast Cancer Tissue and Estrogen Receptor Status.
Shiba , Kambayashi , SAKON , Kawasaki , Kobayashi , Koyama
Breast Cancer. 1996; 3(1):13-17.
PMID: 11091548
DOI: 10.1007/BF02966957.